Tag: Hummingbird Bioscience
Biotherapeutics startup Hummingbird Bioscience brings its total Series B funding to $25 million
Hummingbird Bioscience, a startup focused on developing new treatments for cancer and other diseases, announced today it has added $6 million to its previously announced Series B, bringing the round’s total to $25 million. The extension was led by SK Holdings, and included participation from returning investors including Heritas Capital…
Read More